{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:59:58Z","timestamp":1789387198716,"version":"build-2803163510"},"reference-count":29,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T00:00:00Z","timestamp":1361404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2013,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The epidemiology of invasive mold infections (<jats:styled-content style=\"fixed-case\">IMI<\/jats:styled-content>) in transplant recipients differs based on geography, hosts, preventative strategies, and methods of diagnosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective observational study to evaluate the epidemiology of proven and probable <jats:styled-content style=\"fixed-case\">IMI<\/jats:styled-content>, using prior definitions, among all adult hematopoietic stem cell transplant (<jats:styled-content style=\"fixed-case\">HSCT<\/jats:styled-content>) and solid organ transplant (<jats:styled-content style=\"fixed-case\">SOT<\/jats:styled-content>) recipients in the era of \u201cclassic\u201d culture\u2010based diagnostics (2000\u20132009). Epidemiology was evaluated before and after an initiative was begun to increase bronchoscopy in <jats:styled-content style=\"fixed-case\">HSCT<\/jats:styled-content> recipients after 2005.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 106 patients with one <jats:styled-content style=\"fixed-case\">IMI<\/jats:styled-content> were identified. Invasive aspergillosis (<jats:styled-content style=\"fixed-case\">IA<\/jats:styled-content>) was the most common <jats:styled-content style=\"fixed-case\">IMI<\/jats:styled-content> (69; 65.1%), followed by mucormycosis (9; 8.5%). The overall rate of <jats:styled-content style=\"fixed-case\">IMI<\/jats:styled-content> (and <jats:styled-content style=\"fixed-case\">IA<\/jats:styled-content>) was 3.5% (2.5%) in allogeneic <jats:styled-content style=\"fixed-case\">HSCT<\/jats:styled-content> recipients. The overall incidence for <jats:styled-content style=\"fixed-case\">IMI<\/jats:styled-content> among lung, kidney, liver, and heart transplant recipients was 49, 2, 11, and 10 per 1000 person\u2010years, respectively. The observed rate of <jats:styled-content style=\"fixed-case\">IMI<\/jats:styled-content> among human leukocyte antigen\u2010matched unrelated and haploidentical <jats:styled-content style=\"fixed-case\">HSCT<\/jats:styled-content> recipients increased from 0.6% annually to 3.0% after bronchoscopy initiation (<jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.05). The 12\u2010week mortality among allogeneic <jats:styled-content style=\"fixed-case\">HSCT<\/jats:styled-content>, liver, kidney, heart, and lung recipients with <jats:styled-content style=\"fixed-case\">IMI<\/jats:styled-content> was 52.4%, 47.1%, 27.8%, 16.7%, and 9.5%, respectively. Among allogeneic <jats:styled-content style=\"fixed-case\">HSCT<\/jats:styled-content> (odds ratio [<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>]: 0.07, <jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0.007) and <jats:styled-content style=\"fixed-case\">SOT<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>: 0.22, <jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0.05) recipients with <jats:styled-content style=\"fixed-case\">IA<\/jats:styled-content>, normal platelet count was associated with improved survival. Male gender (<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>: 14.4, <jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0.007) and elevated bilirubin (<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>: 5.7, <jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0.04) were significant predictors of mortality for allogeneic <jats:styled-content style=\"fixed-case\">HSCT<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">SOT<\/jats:styled-content> recipients with <jats:styled-content style=\"fixed-case\">IA<\/jats:styled-content>, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>During the era of culture\u2010based diagnostics, observed rates of <jats:styled-content style=\"fixed-case\">IMI<\/jats:styled-content> were low among all transplants except lung transplant recipients, with relatively higher mortality rates. Diagnostic aggressiveness and host variables impact the reported incidence and outcome of <jats:styled-content style=\"fixed-case\">IMI<\/jats:styled-content> and likely account for institutional variability in multicenter studies. Definitions to standardize diagnoses among <jats:styled-content style=\"fixed-case\">SOT<\/jats:styled-content> recipients are needed.<\/jats:p><\/jats:sec>","DOI":"10.1111\/tid.12060","type":"journal-article","created":{"date-parts":[[2013,2,22]],"date-time":"2013-02-22T03:08:42Z","timestamp":1361502522000},"page":"233-242","source":"Crossref","is-referenced-by-count":124,"title":["Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10\u2010year, single\u2010center experience"],"prefix":"10.1111","volume":"15","author":[{"given":"D.","family":"Neofytos","sequence":"first","affiliation":[{"name":"Department of Medicine The Johns Hopkins Hospital Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Treadway","sequence":"additional","affiliation":[{"name":"Department of Medicine The Johns Hopkins Hospital Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ostrander","sequence":"additional","affiliation":[{"name":"Department of Medicine The Johns Hopkins Hospital Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.D.","family":"Alonso","sequence":"additional","affiliation":[{"name":"Department of Medicine The Johns Hopkins Hospital Baltimore Maryland USA"},{"name":"Department of Medicine Beth Israel Deaconess Medical Center Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.L.","family":"Dierberg","sequence":"additional","affiliation":[{"name":"Department of Medicine The Johns Hopkins Hospital Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Nussenblatt","sequence":"additional","affiliation":[{"name":"Department of Medicine The Johns Hopkins Hospital Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.","family":"Durand","sequence":"additional","affiliation":[{"name":"Department of Medicine The Johns Hopkins Hospital Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.B.","family":"Thompson","sequence":"additional","affiliation":[{"name":"The Johns Hopkins Bloomberg School of Public Health Biostatistics Center Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A.","family":"Marr","sequence":"additional","affiliation":[{"name":"Department of Medicine The Johns Hopkins Hospital Baltimore Maryland USA"},{"name":"Department of Oncology The Johns Hopkins Hospital Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,2,21]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-05-1496"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1086\/313803"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1086\/339202"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1086\/500934"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1086\/510592"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1086\/591969"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1086\/592255"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1086\/595846"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1086\/651263"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1086\/651262"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2010.00492.x"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1086\/652761"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1086\/588660"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2005.03.005"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2010.00499.x"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1086\/657065"},{"key":"e_1_2_7_18_1","first-page":"825","article-title":"Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka D","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2005.09.004"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1086\/652768"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3062.1999.010402.x"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(02)00477-1"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.03.005"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01967060"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1309\/EXBVYAUPENBM285Y"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702045"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1086\/422009"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1086\/503427"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1086\/591458"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.3109\/13693786.2010.510150"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftid.12060","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.12060","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T05:06:16Z","timestamp":1700629576000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tid.12060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,21]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["10.1111\/tid.12060"],"URL":"https:\/\/doi.org\/10.1111\/tid.12060","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,21]]}}}